India’s actions reflect a commitment to humanity, highlighting the role that nations can play in alleviating suffering and advocating for peace. ... Oct 29
Recognition reinforces Avantor's commitment to innovation and leadership for biopharma advancement.... Mar 21
The product will be available at leading pharmacies nationwide, as well as through popular e-pharmacies, ensuring easy accessibility for all individuals seeking effective relief ... Feb 19
Prof Giovanni Zucchelli, DDS, PHD, is the Professor of Periodontology and Implantology at the University of Bologna, Italy. He has received numerous awards for his ... Feb 14
These measures will not only enhance healthcare accessibility in rural areas but also strengthen the overall healthcare ecosystem in our country. ... Feb 02
The product will be available across all leading pharmacies in the country as well as through popular e-pharmacies.... Jan 02
... Dec 14
The product will be manufactured at Lupin’s facility in Pithampur, India... Jul 14
Lupin & its AET Pharma US Inc. (part of Tiefenbacher Group) received an approval for its ANDA from the USFDA... Feb 17
Meloxicam Capsules indicated for the management of osteoarthritis pain... Dec 29
Meloxicam Capsules is the generic equivalent of Vivlodex Capsules of Zyla Life Sciences US, Inc., and indicated for the management of osteoarthritis (OA) pain.... Dec 28
Another USFDA approval for Lupin... Dec 18
Penicillamine Tablets USP, 250 mg, are indicated in the treatment of Wilson’s disease, Cystinuria, and in patients with severe, active rheumatoid arthritis... Dec 01
Cipla today announced that it signed a licensing agreement with a Belgium-based firm, Multi G for the distribution of their COVID-19 Rapid Antibody ... Nov 20
Tacrolimus Capsules USP are indicated for the prophylaxis of organ rejection in adult and pediatric patients receiving allogeneic liver, kidney or heart transplants... Nov 12
... Oct 09
Lupin launches generic version of Novartis's Tykerb Tablets... Sep 30
The tablet already got USFDA clearance earlier... Sep 28
150 mg Single-Dose Vial, having received an approval from the United States Food and Drug Administration (U.S. FDA) earlier.... Sep 28
Pharma major Lupin Limited announced the launch of Divalproex Sodium Extended-Release (ER) Tablets USP, 250 mg and 500 mg, after an approval by U.... Sep 22
... Aug 06
Lupin alliance partner scores another US FDA approval... Aug 06
Now Lupin also launches Favipiravir for mild to moderate Covid infection... Aug 05
Lupin's Meloxicam capsules are a generic equivalent of Vivlodex Capsules of Zyla Life Sciences US.... Jun 03
The inspection for the API facility was conducted by the US FDA between January 13, 2020 and January 17, 2020.... May 14
-Advertisements-